DNAnexus to Showcase Platform Scalability, Versatility, and Security at ASHG 2022 Annual Meeting

Leading human geneticists and bioinformaticians to share latest data-driven insights that can help advance precision medicine and improve patient care

DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the speaker lineup for its customer presentations at the American Society of Human Genetics (ASHG) 2022 Annual Meeting, which is being held in Los Angeles this week. The company will also be showcasing its GxP-compliant platform and new Nextflow pipeline language support capabilities in booth #2103.

“The rapidly evolving genomic and multi-omic ecosystem has created an enormous need for a scalable and compliant analysis platform that drives critical insights from massive datasets,” said Stephen Nuckols, Chief Commercial Officer at DNAnexus. “We look forward to hearing from several visionary scientists about how they are using our platform to push the boundaries of human genetics and tackle the most exciting opportunities in precision medicine.”

FEATURED PRESENTATIONS

Using Genomic Data to Drive Precision Medicine Insights

Wednesday, Oct. 26, 2022; 12:30 pm – 1:30 pm (lunch provided)

Room 306, Convention Center South Building

• Partnering with DNAnexus to Unlock Myriad’s Precise™ Treatment Registry
  
  Kevin Haas, PhD, Chief Technology Officer, Myriad Genetics
• The City of Hope POSEIDON Platform: Driving Cancer Insights with Real-World Data
  
  Samir Courdy, Senior Vice President and Chief Informatics Officer, City of Hope

Detection of Clonal Hematopoiesis in the UK Biobank and Association with Health Outcomes

Wednesday, Oct. 26, 2022; 3:45 pm – 4:15 pm

Theater 2, Convention Center Exhibit Hall

• Kelly Bolton, MD, PhD, Assistant Professor, Washington University School of Medicine
• Ben Busby, PhD, Senior Director of Solution Science, DNAnexus

To register for these presentations, please visit: https://hello.dnanexus.com/american-society-of-human-genetics-2022-conference.

Today, DNAnexus has more than 12,000 users across 48 countries and works with the largest and most innovative pharmaceutical companies, diagnostic laboratories, and academic medical centers around the world, along with the UK Biobank and the FDA. The platform provides a comprehensive cloud environment that was designed to meet the most rigorous standards for quality, security, privacy, and safety.

About DNAnexus

DNAnexus is a leading provider of secure, scalable, and intuitive biomedical data analysis software and bioinformatics applications for the life sciences and healthcare communities. The company actively manages and supports more than 65 petabytes of complex genomic, multi-omic, and clinical datasets on behalf of a growing network of collaborations with large-scale biobanks, as well as leading pharmaceutical, clinical diagnostic, academic research, and government organizations. Scientists across 48 countries are now using the highly collaborative, cloud-based, end-to-end platform to gain data-driven insights that can advance scientific discovery, accelerate precision medicine, and improve patient care. For more information on DNAnexus, please visit www.dnanexus.com or follow the company @DNAnexus.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221025005161/en/